Varaico: Literature-Extracted Genetic Variants

Gene:SLC22A1
Variant:p.R488M
Back to variants list

SLC22A1

NM_003057.3:p.R488M

Associated Papers

Structural insights into human organic cation transporter 1 transport and inhibition.

Zhang S et al.

Cell Discovery, 2024

The full spectrum of OCT1 (SLC22A1) mutations bridges transporter biophysics to drug pharmacogenomics.

Yee SW et al.

Biorxiv : the Preprint Server for Biology, 2023

37333090 (PubMed )
Supplement: media-2.xlsx › S2_gnomAD_v2.1

Hepatic solute carrier transporters and drug therapy: Regulation of expression and impact of genetic variation.

Nies AT et al.

Pharmacology & Therapeutics, 2022

Population pharmacogenomics: an update on ethnogeographic differences and opportunities for precision public health.

Zhou Y et al.

Human Genetics, 2022

Genetic Variant ABCC1 rs45511401 Is Associated with Increased Response to Statins in Patients with Familial Hypercholesterolemia.

Dagli-Hernandez C et al.

Pharmaceutics, 2022

35631530 (PubMed )
Supplement: pharmaceutics-14-00944-s001.zip › pharmaceutics-1634615-supplementary.pdf

Decoding variants in drug-metabolizing enzymes and transporters in solid tumor patients by whole-exome sequencing.

Aboul-Soud MAM et al.

Saudi Journal of Biological Sciences, 2021

33424349 (PubMed )
Supplement: mmc1.xlsx › Sheet1

Expansion of Knowledge on OCT1 Variant Activity In Vitro and In Vivo Using Oct1/2-/- Mice.

Morse BL et al.

Frontiers in Pharmacology, 2021

Effects of Genetic Polymorphism in CYP2D6, CYP2C19, and the Organic Cation Transporter OCT1 on Amitriptyline Pharmacokinetics in Healthy Volunteers and Depressive Disorder Patients.

Matthaei J et al.

Frontiers in Pharmacology, 2021

Variability and Heritability of Thiamine Pharmacokinetics With Focus on OCT1 Effects on Membrane Transport and Pharmacokinetics in Humans.

Jensen O et al.

Clinical Pharmacology and Therapeutics, 2020

Cellular Uptake of Psychostimulants - Are High- and Low-Affinity Organic Cation Transporters Drug Traffickers?

Jensen O et al.

Frontiers in Pharmacology, 2020

The genetic landscape of the human solute carrier (SLC) transporter superfamily.

Schaller L et al.

Human Genetics, 2019

Opioids as Substrates and Inhibitors of the Genetically Highly Variable Organic Cation Transporter OCT1.

Meyer MJ et al.

Journal of Medicinal Chemistry, 2019

Targeted next generation sequencing as a tool for precision medicine.

Gulilat M et al.

Bmc Medical Genomics, 2019

31159795 (PubMed )
Supplement: 12920_2019_527_MOESM1_ESM.xlsx › Table_S6

Effects of SLC22A1 Polymorphisms on Metformin-Induced Reductions in Adiposity and Metformin Pharmacokinetics in Obese Children With Insulin Resistance.

Sam WJ et al.

Journal of Clinical Pharmacology, 2017

Effects of genetic polymorphisms on the OCT1 and OCT2-mediated uptake of ranitidine.

Meyer MJ et al.

Plos One, 2017

OCT1 mediates hepatic uptake of sumatriptan and loss-of-function OCT1 polymorphisms affect sumatriptan pharmacokinetics.

Matthaei J et al.

Clinical Pharmacology and Therapeutics, 2016

Characterization of Disease-Associated Mutations in Human Transmembrane Proteins.

Molnár J et al.

Plos One, 2016

26986070 (PubMed )
Supplement: pone.0151760.s001.xlsx › polymorphism

Global genetic analyses reveal strong inter-ethnic variability in the loss of activity of the organic cation transporter OCT1.

Seitz T et al.

Genome Medicine, 2015

Role of the plasma membrane transporter of organic cations OCT1 and its genetic variants in modern liver pharmacology.

Lozano E et al.

Biomed Research International, 2013

Impact of drug transporter pharmacogenomics on pharmacokinetic and pharmacodynamic variability - considerations for drug development.

Lai Y et al.

Expert Opinion on Drug Metabolism & Toxicology, 2012

Hepatic OATP and OCT uptake transporters: their role for drug-drug interactions and pharmacogenetic aspects.

Fahrmayr C et al.

Drug Metabolism Reviews, 2010

Stereoselective binding of chiral ligands to single nucleotide polymorphisms of the human organic cation transporter-1 determined using cellular membrane affinity chromatography.

Moaddel R et al.

Analytical Biochemistry, 2010

Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver.

Nies AT et al.

Hepatology (baltimore, Md.), 2009

Pharmacogenomics in type II diabetes mellitus management: Steps toward personalized medicine.

Avery P et al.

Pharmacogenomics and Personalized Medicine, 2009

Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1.

Shu Y et al.

Proceedings of the National Academy of Sciences of the United States of America, 2003

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."